Patient Preference Study

NCT00576342 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma
Ocular Hypertension

Interventions

DRUG: AL-3862+timolol ophthalmic suspension
DRUG: Dorzolamide+timolol ophthalmic solution

Sponsor

Alcon Research